James D. Dondero - 17 Mar 2023 Form 4 Insider Report for Paratek Pharmaceuticals, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 Mar 2023, 16:31:10 UTC
Prior SEC filing
29 Mar 2023
Next SEC filing
29 Mar 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James D. Dondero

Key filing fact

James D. Dondero filed Form 4 for Paratek Pharmaceuticals, Inc. on 29 Mar 2023.

Key facts

  • This page summarizes James D. Dondero's Form 4 filing for Paratek Pharmaceuticals, Inc..
  • 5 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 29 Mar 2023, 16:31.

Change

  • Previous filing in this sequence was filed on 29 Mar 2023.
  • Current net transaction value: +$1,282,056.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRTK transaction

Common Stock

Purchase

Transaction value
$352,294
Shares
+234,863
Change %
+12%
Price
$1.50
Shares after
2,134,663
Date
17 Mar 2023
Ownership
See Footnote
Footnotes
F1
PRTK transaction

Common Stock

Purchase

Transaction value
$147,192
Shares
+105,137
Change %
+4.9%
Price
$1.40
Shares after
2,239,770
Date
20 Mar 2023
Ownership
See Footnote
Footnotes
F2
PRTK transaction

Common Stock

Purchase

Transaction value
$421,950
Shares
+242,500
Change %
+23%
Price
$1.74
Shares after
1,307,617
Date
21 Mar 2023
Ownership
See Footnote
Footnotes
F3, F4
PRTK transaction

Common Stock

Purchase

Transaction value
$187,620
Shares
+106,000
Change %
+5.4%
Price
$1.77
Shares after
2,056,000
Date
22 Mar 2023
Ownership
See Footnote
Footnotes
F5
PRTK transaction

Common Stock

Purchase

Transaction value
$173,000
Shares
+100,000
Change %
+4.9%
Price
$1.73
Shares after
2,156,000
Date
23 Mar 2023
Ownership
See Footnote
Footnotes
F6, F7
PRTK holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
50,000
Date
17 Mar 2023
Ownership
See Footnote
Footnotes
F8
PRTK holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,889,060
Date
17 Mar 2023
Ownership
See Footnote
Footnotes
F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

1,851,434 shares are held by Highland Global Allocation Fund, 64,770 shares are held by NexPoint Climate Tech Fund and 218,429 shares are held by NexPoint Event Driven Fund. These entities are managed by NexPoint Asset Management, L.P. ("NexPoint Asset Management"). Mr. Dondero is the sole stockholder and director of Strand Advisors XVI, Inc., NexPoint Asset Management's general partner, and may be deemed to be an indirect beneficial owner of securities held by NexPoint Asset Management. Mr. Dondero disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Footnote F2

1,950,000 shares are held by Highland Global Allocation Fund, 64,770 shares are held by NexPoint Climate Tech Fund and 225,000 shares are held by NexPoint Event Driven Fund. These entities are managed by NexPoint Asset Management. Mr. Dondero is the sole stockholder and director of Strand Advisors XVI, Inc., NexPoint Asset Management's general partner, and may be deemed to be an indirect beneficial owner of securities held by NexPoint Asset Management. Mr. Dondero disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.64 to $1.89, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Footnote F4

Mr. Dondero owns 75% of PCMG Trading Partners XXIII, L.P. ("PCMG") and PCMG owns 99% of Drugcrafters. These entities are ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of the shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Footnote F5

2,056,000 shares are held by Highland Global Allocation Fund, 64,770 shares are held by NexPoint Climate Tech Fund and 225,000 shares are held by NexPoint Event Driven Fund. These entities are managed by NexPoint Asset Management. Mr. Dondero is the sole stockholder and director of Strand Advisors XVI, Inc., NexPoint Asset Management's general partner, and may be deemed to be an indirect beneficial owner of securities held by NexPoint Asset Management. Mr. Dondero disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Footnote F6

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.71 to $1.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Footnote F7

2,156,000 shares are held by Highland Global Allocation Fund, 64,770 shares are held by NexPoint Climate Tech Fund and 225,000 shares are held by NexPoint Event Driven Fund. These entities are managed by NexPoint Asset Management. Mr. Dondero is the sole stockholder and director of Strand Advisors XVI, Inc., NexPoint Asset Management's general partner, and may be deemed to be an indirect beneficial owner of securities held by NexPoint Asset Management. Mr. Dondero disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Footnote F8

50,000 shares are held by NexPoint Real Estate Opportunities Fund which is wholly owned by NexPoint Diversified Real Estate Trust Operating Partnership, L.P., which is wholly owned by NexPoint Diversified Real Estate Trust ("NXDT"). NXDT is advised indirectly by NexPoint Advisors, L.P. ("NP"). Mr. Dondero is the sole member of NP's general partner, and may be deemed to be an indirect beneficial owner of securities held by NP. Mr. Dondero disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Footnote F9

2,889,060 shares are held by a trust of which Mr. Dondero is the beneficiary. Mr. Dondero disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .